Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Is vitamin D deficiency linked to disease activity in juvenile idiopathic arthritis?

Posted by on Jan 20, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if vitamin D levels and disease activity are linked in juvenile idiopathic arthritis (JIA). They found that low vitamin D levels were associated with higher disease activity. Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation in the joints. The cause of JIA is unknown. In JIA, the...

Read More

What is the best strategy to achieve remission in juvenile idiopathic arthritis?

Posted by on Jan 18, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated three treatment strategies to achieve remission in patients with juvenile idiopathic arthritis (JIA). They found that all treatment strategies were effective in achieving remission in JIA. Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation. It causes painful swelling in the joints...

Read More

Intensive treatment – is this the most effective approach to achieving remission in rheumatoid arthritis?

Posted by on Jan 18, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated intensive treatment to achieve remission in rheumatoid arthritis (RA). They found that intensive treatment was effective at achieving remission. Some background Rheumatoid arthritis (RA) is a long-term condition. It is caused by painful inflammation in the joints. To treat RA, patients are prescribed drugs...

Read More

Is it possible to maintain low disease activity in rheumatoid arthritis with low dose baricitinib?

Posted by on Jan 10, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if reducing the dose of baricitinib (BCB; Olumiant) maintained low disease activity (LDA) in rheumatoid arthritis (RA). They found that a lower dose of BCB maintained LDA in some patients while the others could be rescued by switching to the original dose.  Some background Rheumatoid...

Read More

Tofacitinib for the treatment of rheumatoid arthritis: evidence from real-world clinical practice

Posted by on Dec 25, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed information on the use of tofacitinib (Xeljanz) for the treatment of rheumatoid arthritis (RA). They found that tofacitinib is effective and well-tolerated for patients with RA. Some background Tofacitinib (TFB) is a new drug to treat rheumatoid arthritis (RA). It blocks a type of enzyme...

Read More

Does tocilizumab increase cardiovascular risk in patients with rheumatoid arthritis?

Posted by on Dec 16, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if tocilizumab (TCZ; Actemra) increases cardiovascular (CVD) risk in patients with rheumatoid arthritis (RA). They found that CVD risk associated with TCZ was similar to other biological drugs.  Some background Rheumatoid arthritis (RA) is caused by excessive inflammation. Inflammation leads to pain and...

Read More

Exercise and anti-TNF medication – can this combination improve cardiovascular health in patients with rheumatoid arthritis?

Posted by on Dec 3, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if exercise and anti-TNF medication can improve cardiovascular health (CVH) in patients with rheumatoid arthritis (RA). They found that combining exercise and anti-TNF medication improved CVH in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition caused by inflammation in the joints....

Read More

Etanercept and Abatacept: is there a risk of heart failure in patients with rheumatoid arthritis?

Posted by on Nov 25, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the risk of heart failure in patients treated with either etanercept (Enbrel) or abatacept (Orencia) for rheumatoid arthritis (RA). They found that these drugs do not increase the risk of heart failure. Some background Rheumatoid arthritis (RA) is caused by chronic inflammation. This causes pain and swelling...

Read More

Managing flare-ups in rheumatoid arthritis: can etanercept improve disease symptoms?

Posted by on Nov 10, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if etanercept is effective at treating flare-ups in patients with rheumatoid arthritis. They found that etanercept reduces disease activity following flare-ups in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition caused by inflammation. In RA, inflammation causes the damage to...

Read More